Get App
YOU ARE HERE >  Moneycontrol Markets > Announcements Finance - InvestmentsAnnouncement - Lifeline Drugs
Lifeline Drugs
BSE: 506113NSE: ISIN: INE776N01028

18th-Jan-2020 20:14Source: BSE

Lifeline Drugs & Pharma - Announcement under Regulation 30 (LODR)-Change in Management

In reference to the captioned subject and in accordance with Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulation, 2015, you are hereby informed that, in the meeting of the Board of Director of the Company, which is held today on Wednesday, May 29, 2019 from 11:00 pm at the Registered office of the Company Situated at 204, B-Wing, New Prabhat SRA CHS Ltd., Chikuwadi, Western Express Highway, Andheri East, Mumbai - 400099. The Board has considered and approved the appointment of CA Devroop Ghosh, a Member of the Institute Chartered Accountant of India as a Chief Financial Officer (CFO).

Follow us on